NCT03701386

Brief Summary

The placenta accreta spectrum (PAS)is one of the most common reasons for cesarean hysterectomy Which associated with high rates of severe maternal morbidity (40%-50%), with reported mortality rates up to 7%. And, a cesarean hysterectomy might not be considered first-line treatment for women who have a strong desire for future fertility. Conservative management of PAS defines all procedures that aim to avoid peripartum hysterectomy and its related morbidity and consequences. The main types of conservative management which have been described in the literature: the extirpative technique (manual removal of the placenta); leaving the placenta in situ or the expectant approach; one-step conservative surgery and the Triple-P procedure. These methods have been used alone or in combination and in many cases with additional procedures such as those proposed by interventional radiology.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 10, 2018

Completed
22 days until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

December 13, 2018

Status Verified

December 1, 2018

Enrollment Period

3 years

First QC Date

October 5, 2018

Last Update Submit

December 11, 2018

Conditions

Keywords

cesarean sectionplacenta accreta spectrumN&H sandwich technique

Outcome Measures

Primary Outcomes (1)

  • intraoperative blood loss

    measures the intraoperative blood loss by direct and gravimetric methods

    during the operation

Secondary Outcomes (4)

  • postoperative blood loss

    24 hours postoperative

  • need of blood transfusion

    ist 24 hours postoperative

  • need of other surgical maneuvers

    during the operation

  • operative time

    during the operation

Study Arms (2)

cesarean hysterectomy

ACTIVE COMPARATOR

Elective Cesarean hysterectomy will be planned at 37-38 weeks of gestation. An adequate amount of blood products was prepared to be available for transfusion. The operation will be performed by the same multidisciplinary team, including two expert obstetricians, an assistant, an expert anesthesiologist, and a pediatrician.

Procedure: cesarean hysterectomy

N&H sandwich technique

EXPERIMENTAL

In the N\&H group, after acceptable control of bleeding from the placental bed, the internal os of the cervix was identified a double uterine compression suture at the lower uterine segment with inflated Foley's catheter balloon tamponade was performed

Procedure: N&H sandwich technique

Interventions

Elective cesarean hysterectomy will be planned at 37-38 weeks of gestation. An adequate amount of blood products was prepared to be available for transfusion. Delivery will be performed by the same multidisciplinary team, including two expert obstetricians, an assistant, an expert anesthesiologist, and a pediatrician.

cesarean hysterectomy

In the N\&H group, after acceptable control of bleeding from the placental bed, the internal os of the cervix was identified a double uterine compression suture at the lower uterine segment with inflated Foley's catheter balloon tamponade will be performed

N&H sandwich technique

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant female with placenta accreta spectrum
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • all pregnant women with a full-term pregnancy with placenta accreta spectrum

You may not qualify if:

  • Patients with a cardiac, hepatic, renal or thromboembolic disease.
  • patients with pelvic endometriosis and adnexal mass.
  • those presented with severe antepartum hemorrhage will be excluded
  • known coagulopathy
  • twin pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aswan University

Aswān, 81528, Egypt

RECRUITING

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Officials

  • hany f sallam, md

    Aswan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

hany f sallam, md

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
no masking
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The eligible participant will be allocated to groups, group one will receive cesarean hysterectomy and group 2 will be received N\&H sandwich technique
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

October 5, 2018

First Posted

October 10, 2018

Study Start

November 1, 2018

Primary Completion

October 30, 2021

Study Completion

January 1, 2022

Last Updated

December 13, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations